MHB018A Treatment in Patients With Chronic Thyroid Eye Disease

Clinical trial NCT07257185 · RECRUITING

Trial details

NCT number: NCT07257185
Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Thyroid Eye Disease (TED)

Start date: 2026-03-17
Primary completion: 2027-08-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.